Hackensack Meridian Health Oncology

Zilo+Ibr Combination Shows Promise in John Theurer Cancer Center at Hackensack University Medical Center Study

Phase 1/2 study offers encouraging results for MZL, CLL and MZL

John Theurer Cancer Center at Hackensack University Medical Center Research Helps Establish Durable Responses After KTE-X19

ZUMA-2 study long-range follow-up in relapsed/refractory mantle cell lymphoma (R/R MCL)

Researchers with John Theurer Cancer Center at Hackensack University Medical Center Publish V-FAST Trial Outcomes

Outcomes with CPX-351 plus Midostaurin in adults with newly diagnosed acute myeloid leukemia by FLT3 mutation type

MyDrug Platform Trial Addresses Mutation Challenges to Multiple Myeloma Clinical Trial Enrollment

John Theurer Cancer Center study measures efficacy and safety of daratumumab, ixazomib, pomalidomide, and dexamethasone in patients with functionally high-risk multiple myeloma

John Theurer Cancer Center at Hackensack University Medical Center Research Finds Fludarabine Exposure Target Window Tied to Improved Survival for B-NHL

ASH presentation also examines negative effects of Flu over and underexposure common with body-surface areas based dosing prior to CD19 CAR T-Cell therapy

John Theurer Cancer Center at Hackensack University Medical Center Research Applies Best-in-Class Liquid Biopsy Technology for Patients with Myeloid Neoplasms

Study finds targeted NGS can reliably and efficiently provide enough information in one test on the blood to help refine diagnostics in AML and MDS

John Theurer Cancer Center at Hackensack University Medical Center Researchers Co-Author ZUMA-2 Three-Year Follow-Up on CAR T-Cell for Mantle Cell Lymphoma

Longest follow-up of CAR T-Cell in MCL to date showed long-term benefits for patients

Researchers at John Theurer Cancer Center at Hackensack University Medical Center Study CLL Retreatment with Venetoclax

Retrospective outcomes and safety data study opens potential for additional therapy after initial treatment with BTKi and venetoclax

John Theurer Cancer Center at Hackensack University Medical Center Review Examines Exosomes as Source of Circulating Tumor Biomarkers

Exosomes produced by cancer cells evaluated for feasibility and potential as a minimally invasive liquid biopsy

Hackensack University Medical Center Research Applies a Novel Platform of Dual DNA/RNA Signatures Using Liquid Biopsies for Patients with AML or MDS

Study finds targeted NGS can reliably and efficiently provide in one test enough information on the blood to help refine molecular diagnostic in AML and MDS

John Theurer Cancer Center at Hackensack University Medical Center Research Demonstrates Increase in Early Onset Colorectal Cancer

Research contributes evidence of incidence increase under age 50